NOVEL SERUM BIOMARKERS FOR SARCOPENIA: INSIGHTS FROM CLINICAL DATA AND STUDIES USING C2C12 MYOBLASTS

Abstract

Introduction: Sarcopenia, the progressive loss of skeletal muscle mass and function, is a critical public health issue among older adults with underlying functional decline and increased risk of adverse health outcomes.